Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS

Abstract

AbstractBackgroundThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.MethodsFor the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.ResultsAt the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).ConclusionsA low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.